{"id":625089,"title":"ARCHIVED - Regulatory Issues Associated with the Development and Licensing of SARS Vaccines and Immunotherapy Products - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T08:22:00.495000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/regulatory-issues-associated-development-licensing-sars-vaccines-immunotherapy-products.html","snippet":"ARCHIVED - Regulatory Issues Associated with the Development and Licensing of SARS Vaccines and Immunotherapy Products We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can…","rawSnapshotUrl":"/api/snapshots/raw/625089","browseUrl":"https://replay.healtharchive.ca/job-6/20260227082200/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/regulatory-issues-associated-development-licensing-sars-vaccines-immunotherapy-products.html#ha_snapshot=625089","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}